Close Menu

NEW YORK – Personal Genome Diagnostics (PGDx) said on Wednesday that it has entered a strategic collaboration with the Mayo Clinic to improve clinical diagnostic oncology solutions. 

As part of the collaboration, the partners will focus on optimizing technology and conducting clinical utility studies for liquid biopsy and tissue-based genomic applications, combining Mayo Clinic's clinical knowledge and expertise in oncology and PGDx's experience with genomic technology. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.